MOASC Cary Presant Young Investigator Award

$25,000 to accelerate clinical & translational oncology—1-year term

Program Summary

Fuel a bold new research project that advances clinical and translational oncology. Proposals must be scoped for a 1-year term and reflect the available funding. Applications will be evaluated for scientific merit and feasibility, with final funding decisions made by the MOASC Board of Directors.

Applicant Eligibility

• MD or DO with intent to practice clinical oncology
• Initiated or completed an ACGME-accredited fellowship in hematology and/or oncology
• ≤ 7 years post-fellowship completion
• Based at a Southern California institution for the full 1-year award period

Award at a Glance

• Funding: $25,000
• Number of Awards: 1
• Term: 1 year
• Focus: Clinical and translational research that advances treatment approaches for patients with cancer

Key Dates

• Submission Deadline: Friday, December 5, 2025
• Decision Date: Friday, February 6, 2026
• Presentation at MOASC Annual Meeting: Saturday, March 21, 2026
• Start of Grant Term: Wednesday, July 1, 2026
• End of Grant Term: Wednesday, June 30, 2027

How to Apply

Email the entire application as a single PDF to [email protected] by Friday, December 5, 2025.

Supported by a grant from AVEO Oncology (“AVEO”), an oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer.